As Pear Therapeutics’ financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on the road for digital therapeutics, or a sign of darker ...

Pear Therapeutics received market authorization from the FDA for its insomnia digital therapeutic, Somryst. It is Pear’s third product to receive FDA clearance, and the first product to be ...

Pear Therapeutics is also working on an opioid version of the cognitive behavioural therapy app, named reSET-O, for which it hopes to gain FDA approval for patients with opioid use disorder who ...

Recently, however, SoftBank has dabbled in digital healthcare. It backed Pear Therapeutics, an app-based treatment tool for people experiencing insomnia or substance abuse disorders, in December ...